Locally Advanced Lung Non-Small Cell Carcinoma Clinical Trials

15 clinical trials for Locally Advanced Lung Non-Small Cell Carcinoma across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation — RECRUITING · PHASE1
• Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer — RECRUITING · PHASE1
• Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer — RECRUITING · PHASE3
• Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors — RECRUITING · PHASE1
• Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation — RECRUITING · NA
• Improving the Success Rate for Thoracic Radiotherapy Through Specific Cardiac Substructure Dosimetry: Location Matters. (LOCATION MATTERS) — RECRUITING
• Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLC — ACTIVE_NOT_RECRUITING · PHASE1
• Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer — ACTIVE_NOT_RECRUITING · NA
• Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial — COMPLETED · PHASE1
• Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer — COMPLETED · PHASE1
• ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy — TERMINATED · PHASE2
• Stereotactic Ablative Radiotherapy in Locally Advanced Non Small Cell Lung Cancer — COMPLETED · NA

Refine this search